Invention Grant
US08143307B2 Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same
有权
苯并噻吩-2-羰基胍衍生物及其制备方法和含有它们的药物组合物
- Patent Title: Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same
- Patent Title (中): 苯并噻吩-2-羰基胍衍生物及其制备方法和含有它们的药物组合物
-
Application No.: US11794238Application Date: 2005-12-27
-
Publication No.: US08143307B2Publication Date: 2012-03-27
- Inventor: Kyu Yang Yi , SunKyung Lee , Jee Hee Suh , Nak Jeong Kim , Hyunsuk Lee , Byung-Ho Lee , Sung-eun Yoo , Kyung-Hee Lee , Yong Oh Lee
- Applicant: Kyu Yang Yi , SunKyung Lee , Jee Hee Suh , Nak Jeong Kim , Hyunsuk Lee , Byung-Ho Lee , Sung-eun Yoo , Kyung-Hee Lee , Yong Oh Lee
- Applicant Address: KR Taejeon-si
- Assignee: Korea Research Institute of Chemical Technology
- Current Assignee: Korea Research Institute of Chemical Technology
- Current Assignee Address: KR Taejeon-si
- Agency: Frommer Lawrence & Haug LLP
- Agent Ronald R Santucci
- Priority: KR10-2004-0112856 20041227
- International Application: PCT/KR2005/004573 WO 20051227
- International Announcement: WO2006/071047 WO 20060706
- Main IPC: A61K31/381
- IPC: A61K31/381 ; C07D333/56

Abstract:
The present invention is related to benzothiophen-2-carbonylguanidine derivatives, a preparation method thereof, and pharmaceutical compositions containing the same. The derivatives have potent inhibitory effect on the sodium/hydrogen exchanger NHE-I, improve the functional recovery of ischemia/reperfusion-induced heart injury in isolated ischemic heart models, and significantly reduce the myocardiac infarct size in in vivo ischemic animal models, thereby showing excellent cardioprotective effects. Also, the derivatives are protective of both neuronal cells and the brain as proven by their protective effects on neuronal cells from necrosis and apoptosis and by their ability to significantly reduce cerebral infarct sizes in in vivo ischemic brain models. The derivatives can be effectively used for the prevention and treatment of ischemic heart diseases such as myocardiac infarction, arrhythmia, angina pectoris and the like, and cerebrovascular diseases such as cerebral stroke and be used as cardioprotective agents to the patients undergoing reperfusion therapy including chemicals such as thrombolytic agents, or surgery such as coronary artery bypass and percutaneous transluminal coronary angioplasty.
Public/Granted literature
Information query